ArticleFrontiers in pharmacology2024

Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes.

Ninoschka C D'Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.